Stem cells and stem cell-derived tissues and their use in safety assessment

Journal of Biological Chemistry

Volumn 289, Issue 8, 2014, Pages 4555-4561

  Kolaja, Kyle ^a  

^a Cellular Dynamics International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOLOGY; STEM CELLS;

ANIMAL MODEL; GENETIC BACKGROUNDS; HIGH PURITY; NEW APPROACHES; RISK OF EXPOSURES; SAFETY ASSESSMENTS; STATE OF THE ART; THREE-DIMENSIONAL MODEL;

TISSUE;

BIOLOGICAL MARKER;

BIOLOGICAL MODEL; DRUG DEVELOPMENT; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; LIVER CELL; MEDICAL RESEARCH; NERVE CELL; NEUROTOXICOLOGY; NONHUMAN; PLURIPOTENT STEM CELL; PLURIPOTENT STEM CELL DERIVED TISSUE; PRIORITY JOURNAL; REVIEW; SCREENING; TISSUE DIFFERENTIATION; TISSUE ENGINEERING; TOXICOLOGY;

CARDIOVASCULAR; DRUG DEVELOPMENT; DRUG DISCOVERY; EMBRYONIC STEM CELL; HEPATOCYTE; INDUCED PLURIPOTENT STEM CELLS; NEURONS; STEM CELLS; TOXICOLOGY;

ANIMALS; HEPATOCYTES; HUMANS; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; NEURONS; STEM CELLS; TISSUE ENGINEERING;

EID: 84894486120     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R113.481028     Document Type: Review

References (67)

1. Williams, E. S., Panko, J., and Paustenbach, D. J. (2009) The European Union's REACH regulation: a review of its history and requirements. Crit. Rev. Toxicol. 39, 553-575
2. Thomas, C. E., and Will, Y. (2012) The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery. Expert Opin. Drug Discov. 7, 109-122
3. Seiler, A., Visan, A., Pohl, I., Genschow, E., Buesen, R., and Spielmann, H. (2002) Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development using murine embryonic stem cells (D3 cells). ALTEX 19, Suppl. 1, 55-63
4. Genschow, E., Spielmann, H., Scholz, G., Seiler, A., Brown, N., Piersma, A., Brady, M., Clemann, N., Huuskonen, H., Paillard, F., Bremer, S., and Becker, K. (2002) The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods. Altern. Lab. Anim. 30, 151-176
5. Scholz, G., Genschow, E., Pohl, I., Bremer, S., Paparella, M., Raabe, H., Southee, J., and Spielmann, H. (1999) Prevalidation of the embryonic stem cell test (EST)-a new in vitro embryotoxicity test. Toxicol. In Vitro 13, 675-681
6. Seiler, A. E., and Spielmann, H. (2011) The validated embryonic stem cell test to predict embryotoxicity in vitro. Nat. Protoc. 6, 961-978
7. Paquette, J. A., Kumpf, S. W., Streck, R. D., Thomson, J. J., Chapin, R. E., and Stedman, D. B. (2008) Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry. Birth Defects Res. B Dev. Reprod. Toxicol. 83, 104-111
8. Panzica-Kelly, J. M., Brannen, K. C., Ma, Y., Zhang, C. X., Flint, O. P., Lehman-McKeeman, L. D., and Augustine-Rauch, K. A. (2013) Establishment of a molecular embryonic stem cell developmental toxicity assay. Toxicol. Sci. 131, 447-457
9. Hurtt, M. E., Daston, G., Davis-Bruno, K., Feuston, M., Silva Lima, B., Makris, S., McNerney, M. E., Sandler, J. D., Whitby, K., Wier, P., and Cappon, G. D. (2004) Juvenile animal studies: testing strategies and design. Birth Defects Res. B Dev. Reprod. Toxicol. 71, 281-288
10. Schardein, J. L., Schwetz, B. A., and Kenel, M. F. (1985) Species sensitivities and prediction of teratogenic potential. Environ. Health Perspect. 61, 55-67
11. Spielmann, H. (2009) The way forward in reproductive/developmental toxicity testing. Altern. Lab. Anim. 37, 641-656
12. Burridge, P. W., Thompson, S., Millrod, M. A., Weinberg, S., Yuan, X., Peters, A., Mahairaki, V., Koliatsos, V. E., Tung, L., and Zambidis, E. T. (2011) A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS ONE 6, e18293
13. Brons, I. G., Smithers, L. E., Trotter, M. W., Rugg-Gunn, P., Sun, B., Chuva de Sousa Lopes, S. M., Howlett, S. K., Clarkson, A., Ahrlund-Richter, L., Pedersen, R. A., and Vallier, L. (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195
14. Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J., Evans, E. P., Mack, D. L., Gardner, R. L., and McKay, R. D. (2007) New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199
15. Mayshar, Y., Yanuka, O., and Benvenisty, N. (2011) Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells. J. Cell. Mol. Med. 15, 1393-1401
16. Colleoni, S., Galli, C., Gaspar, J. A., Meganathan, K., Jagtap, S., Hescheler, J., Sachinidis, A., and Lazzari, G. (2011) Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol. Sci. 124, 370-377
17. Kleinstreuer, N. C., Smith, A. M., West, P. R., Conard, K. R., Fontaine, B. R., Weir-Hauptman, A. M., Palmer, J. A., Knudsen, T. B., Dix, D. J., Donley, E. L., and Cezar, G. G. (2011) Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics. Toxicol. Appl. Pharmacol. 257, 111-121
18. Kameoka, S., Babiarz, J., Kolaja, K., and Chiao, E. (2014) Development of a high throughput, in vitro human pluripotent stem cell test for the identification of potentially teratogenic compounds. Toxicol. Sci. 137, 76-90
19. Force, T., and Kolaja, K. L. (2011) Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. Nat. Rev. Drug Discov. 10, 111-126
20. Raschi, E., Ceccarini, L., De Ponti, F., and Recanatini, M. (2009) hERGrelated drug toxicity and models for predicting hERG liability and QT prolongation. Expert Opin. Drug Metab. Toxicol. 5, 1005-1021
21. Skrzypiec-Spring, M., Grotthus, B., Szelag, A., and Schulz, R. (2007) Isolated heart perfusion according to Langendorff-still viable in the new millennium. J. Pharmacol. Toxicol. Methods 55, 113-126
22. Caspi, O., Itzhaki, I., Kehat, I., Gepstein, A., Arbel, G., Huber, I., Satin, J., and Gepstein, L. (2009) In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev. 18, 161-172
23. Liang, H., Matzkies, M., Schunkert, H., Tang, M., Bonnemeier, H., Hescheler, J., and Reppel, M. (2010) Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening. Cell. Physiol. Biochem. 25, 459-466
24. Babiarz, J. E., Ravon, M., Sridhar, S., Ravindran, P., Swanson, B., Bitter, H., Weiser, T., Chiao, E., Certa, U., and Kolaja, K. L. (2012) Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling. Stem Cells Dev. 21, 1956-1965
25. Dick, E., Rajamohan, D., Ronksley, J., and Denning, C. (2010) Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. Biochem. Soc. Trans. 38, 1037-1045
26. Laposa, R. R. (2011) Stem cells for drug screening. J. Cardiovasc. Pharmacol. 58, 240-245
27. Guo, L., Abrams, R. M., Babiarz, J. E., Cohen, J. D., Kameoka, S., Sanders, M. J., Chiao, E., and Kolaja, K. L. (2011) Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol. Sci. 123, 281-289
28. Taegtmeyer, H., Sen, S., and Vela, D. (2010) Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann. N.Y. Acad. Sci. 1188, 191-198
29. Boudou, T., Legant, W. R., Mu, A., Borochin, M. A., Thavandiran, N., Radisic, M., Zandstra, P. W., Epstein, J. A., Margulies, K. B., and Chen, C. S. (2012) A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng. Part A 18, 910-919
30. Willems, E., Bushway, P. J., and Mercola, M. (2009) Natural and synthetic regulators of embryonic stem cell cardiogenesis. Pediatr. Cardiol. 30, 635-642
31. Paci, M., Sartiani, L., Del Lungo, M., Jaconi, M., Mugelli, A., Cerbai, E., and Severi, S. (2012) Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes. Biomed. Eng. Online 11, 61
32. Otsuji, T. G., Minami, I., Kurose, Y., Yamauchi, K., Tada, M., and Nakatsuji, N. (2010) Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: qualitative effects on electrophysiological responses to drugs. Stem Cell Res. 4, 201-213
33. Kamakura, T., Makiyama, T., Sasaki, K., Yoshida, Y., Wuriyanghai, Y., Chen, J., Hattori, T., Ohno, S., Kita, T., Horie, M., Yamanaka, S., and Kimura, T. (2013) Ultrastructural maturation of human induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ. J. 77, 1307-1314
34. Ma, J., Guo, L., Fiene, S. J., Anson, B. D., Thomson, J. A., Kamp, T. J., Kolaja, K. L., Swanson, B. J., and January, C. T. (2011) High purity human induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am. J. Physiol. Heart Circ. Physiol. 301, H2006-H2017
35. Braam, S. R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R., and Mummery, C. L. (2010) Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 4, 107-116
36. Misner, D. L., Frantz, C., Guo, L., Gralinski, M. R., Senese, P. B., Ly, J., Albassam, M., and Kolaja, K. L. (2012) Investigation of mechanism of drug-induced cardiac injury and torsades de pointes in cynomolgus monkeys. Br. J. Pharmacol. 165, 2771-2786
37. Cohen, J. D., Babiarz, J. E., Abrams, R. M., Guo, L., Kameoka, S., Chiao, E., Taunton, J., and Kolaja, K. L. (2011) Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations. Toxicol. Appl. Pharmacol. 257, 74-83
38. Dolci, A., Dominici, R., Cardinale, D., Sandri, M. T., and Panteghini, M. (2008) Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am. J. Clin. Pathol. 130, 688-695
39. Andersson, H., Steel, D., Asp, J., Dahlenborg, K., Jonsson, M., Jeppsson, A., Lindahl, A., Kagedal, B., Sartipy, P., and Mandenius, C. F. (2010) Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells. J. Biotechnol. 150, 175-181
40. Rana, P., Anson, B., Engle, S., and Will, Y. (2012) Characterization of human induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. Toxicol. Sci. 130, 117-131
41. Pointon, A., Abi-Gerges, N., Cross, M. J., and Sidaway, J. E. (2013) Phenotypic profiling of structural cardiotoxins in vitro reveals dependency on multiple mechanisms of toxicity. Toxicol. Sci. 132, 317-326
42. Farina, M., Aschner, M., and Rocha, J. B. (2011) Oxidative stress in MeHginduced neurotoxicity. Toxicol. Appl. Pharmacol. 256, 405-417
43. Ni, M., Li, X., Rocha, J. B., Farina, M., and Aschner, M. (2012) Glia and methylmercury neurotoxicity. J. Toxicol. Environ. Health A 75, 1091-1101
44. Sørensen, A. T., Rogelius, N., Lundberg, C., and Kokaia, M. (2011) Activity-dependent long-term plasticity of afferent synapses on grafted stem/ progenitor cell-derived neurons. Exp. Neurol. 229, 274-281
45. Harrill, J. A., Freudenrich, T. M., Robinette, B. L., and Mundy, W. R. (2011) Comparative sensitivity of human and rat neural cultures to chemicalinduced inhibition of neurite outgrowth. Toxicol. Appl. Pharmacol. 256, 268-280
46. Robinette, B. L., Harrill, J. A., Mundy, W. R., and Shafer, T. J. (2011) In vitro assessment of developmental neurotoxicity: use of microelectrode arrays to measure functional changes in neuronal network ontogeny. Front. Neuroeng. 4, 1
47. Whitemarsh, R. C., Strathman, M. J., Chase, L. G., Stankewicz, C., Tepp, W. H., Johnson, E. A., and Pellett, S. (2012) Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicol. Sci. 126, 426-435
48. Lappalainen, R. S., Salomäki, M., Ylä-Outinen, L., Heikkilä, T. J., Hyttinen, J. A., Pihlajamäki, H., Suuronen, R., Skottman, H., and Narkilahti, S. (2010) Similarly derived and cultured hESC lines show variation in their developmental potential towards neuronal cells in long-term culture. Regen. Med 5, 749-762
49. Ylä-Outinen, L., Heikkilä, J., Skottman, H., Suuronen, R., Aänismaa, R., and Narkilahti, S. (2010) Human cell-based micro electrode array platform for studying neurotoxicity. Front. Neuroeng. 3, 111
50. Xu, X., Lei, Y., Luo, J., Wang, J., Zhang, S., Yang, X. J., Sun, M., Nuwaysir, E., Fan, G., Zhao, J., Lei, L., and Zhong, Z. (2013) Prevention of amyloid induced toxicity in human iPS cell-derived neurons by inhibition of cyclin-dependent kinases and associated cell cycle events. Stem Cell Ress 10, 213-227
51. Han, Y., Miller, A., Mangada, J., Liu, Y., Swistowski, A., Zhan, M., Rao, M. S., and Zeng, X. (2009) Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS ONE 4, e7155
52. Bai, X., Yan, Y., Canfield, S., Muravyeva, M. Y., Kikuchi, C., Zaja, I., Corbett, J. A., and Bosnjak, Z. J. (2013) Ketamine enhances human neural stem cell proliferation and induces neuronal apoptosis via reactive oxygen species-mediated mitochondrial pathway. Anesth. Analg. 116, 869-880
53. Baxter, M. A., Rowe, C., Alder, J., Harrison, S., Hanley, K. P., Park, B. K., Kitteringham, N. R., Goldring, C. E., and Hanley, N. A. (2010) Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Res. 5, 4-22
54. Brolén, G., Sivertsson, L., Björquist, P., Eriksson, G., Ek, M., Semb, H., Johansson, I., Andersson, T. B., Ingelman-Sundberg, M., and Heins, N. (2010) Hepatocyte-like cells derived from human embryonic stem cells specifically via definitive endoderm and a progenitor stage. J. Biotechnol. 145, 284-294
55. Ek, M., Söderdahl, T., Küppers-Munther, B., Edsbagge, J., Andersson, T. B., Björquist, P., Cotgreave, I., Jernström, B., Ingelman-Sundberg, M., and Johansson, I. (2007) Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells. Biochem. Pharmacol. 74, 496-503
56. Basma, H., Soto-Gutiérrez, A., Yannam, G. R., Liu, L., Ito, R., Yamamoto, T., Ellis, E., Carson, S. D., Sato, S., Chen, Y., Muirhead, D., Navarro-Alvarez, N., Wong, R. J., Roy-Chowdhury, J., Platt, J. L., Mercer, D. F., Miller, J. D., Strom, S. C., Kobayashi, N., and Fox, I. J. (2009) Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 136, 990-999
57. Rambhatla, L., Chiu, C. P., Kundu, P., Peng, Y., and Carpenter, M. K. (2003) Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant. 12, 1-11
58. Moore, R. N., and Moghe, P. V. (2009) Expedited growth factor-mediated specification of human embryonic stem cells toward the hepatic lineage. Stem Cell Res 3, 51-62
59. Duan, Y., Ma, X., Zou, W., Wang, C., Bahbahan, I. S., Ahuja, T. P., Tolstikov, V., and Zern, M. A. (2010) Differentiation and characterization of metabolically functioning hepatocytes from human embryonic stem cells. Stem Cells 28, 674-686
60. Söderdahl, T., Küppers-Munther, B., Heins, N., Edsbagge, J., Björquist, P., Cotgreave, I., and Jernström, B. (2007) Glutathione transferases in hepatocyte-like cells derived from human embryonic stem cells. Toxicol. In Vitro 21, 929-937
61. Shirahashi, H., Wu, J., Yamamoto, N., Catana, A., Wege, H., Wager, B., Okita, K., and Zern, M. A. (2004) Differentiation of human and mouse embryonic stem cells along a hepatocyte lineage. Cell Transplant. 13, 197-211
62. Shiraki, N., Umeda, K., Sakashita, N., Takeya, M., Kume, K., and Kume, S. (2008) Differentiation of mouse and human embryonic stem cells into hepatic lineages. Genes Cells 13, 731-746
63. Ramasamy, T. S., Yu, J. S., Selden, C., Hodgson, H., and Cui, W. (2013) Application of three-dimensional culture conditions to human embryonic stem cell-derived definitive endoderm cells enhances hepatocyte differentiation and functionality. Tissue Eng. Part A 19, 360-367
64. Nagamoto, Y., Tashiro, K., Takayama, K., Ohashi, K., Kawabata, K., Sakurai, F., Tachibana, M., Hayakawa, T., Furue, M. K., and Mizuguchi, H. (2012) The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets. Biomaterials 33, 4526-4534
65. Takayama, K., Inamura, M., Kawabata, K., Katayama, K., Higuchi, M., Tashiro, K., Nonaka, A., Sakurai, F., Hayakawa, T., Furue, M. K., and Mizuguchi, H. (2012) Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4β transduction. Mol. Ther. 20, 127-137
66. Li, W., Jiang, K., and Ding, S. (2012) Concise review: a chemical approach to control cell fate and function. Stem Cells 30, 61-68
67. Nakamura, N., Saeki, K., Mitsumoto, M., Matsuyama, S., Nishio, M., Saeki, K., Hasegawa, M., Miyagawa, Y., Ohkita, H., Kiyokawa, N., Toyoda, M., Akutsu, H., Umezawa, A., and Yuo, A. (2012) Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays. Cell. Reprogram. 14, 171-185